SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : CDMA, Globalstar versus Iridium, Inmarsat, etc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dougjn who wrote (329)11/14/1997 7:51:00 PM
From: Maurice Winn  Read Replies (1) of 381
 
Doug, thanks for that! Yes, monoclonal antibodies in general and Coulter's in particular are hopeful lines of development. At present, they are still treating cancer in a stone age way. Hunt down a tree which produces an approximation of a suitable toxin, then poison yourself and hopefully the cancer cells are delicate enough that they die faster than you do. Which is not always the case. Most people get too much damage from the chemicals before the cancer is dead! To help out, blast yourself with nuclear fallout as the cancer cells are a bit more fussy about their lifestyle than normal cells. Bad luck about the leukaemia and other cancers that causes! I think the medical field is badly in need of the likes of Irwin Jacobs and co who apply intelligence rather than brute force.

I've got a kilo or two of printouts, and lots of urls on the topic of NHL now. My brain is full of only recently familiar words and I'm waiting for them to form some sort of pattern in my head.

At present, I have no idea which are the best molecular approaches to NHL nor which is the best company to find them. There seems to be a bit of competition. Understandably given the dollars that await a champion solution. How much would you pay for a Globalstar handset? How much for an NHL cure? There is a BIG difference.

In talking to an endocrinologist friend, she says that there is a big surplus of researchers but a shortage of money. There are plenty of customers. The risk to investment money is pretty high. FDA requirements and delays seem costly though there have been improvements. There also seem to be plenty of ideas to investigate.
So the main need seems to be us good old head-on-the-block courageous investors who pick Qualcomm and Globalstar out of the morass of prospects on offer several years ago. Of course we like to keep our head securely attached to our shoulders so are rather circumspect about the latest great idea.

But a big winner or two or three there will be. Now, which are they?

Thanks again for the info.
Mqurice
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News